Search companies

Live

Tuesday, 17 November 2026 · 586 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Algorae Issues Directors’ Performance Rights as Three Directors’ Interests Change

1AI: $0.009 +12.50% · MC: $18M

Algorae Pharmaceuticals issued 90 million unquoted performance rights as director remuneration after shareholder approval, completing the issue proposed the previous day. Director notices also report changes in interests linked to the rights issue; the supplied notice excerpt identifies David Hainsworth’s indirect acquisition of rights, while the other directors’ details are truncated.

Source announcements: 2026-11-11 18:02 to 2026-11-11 18:10 Sydney time
Story updated 2026-11-11 18:17 Sydney time
SourcesNotification regarding unquoted securities - 1AIChange of Director's Interest Notice - DH, DG, TV
Comments